drugset / Trial / NCT02509923
To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate pharmacokinetics and pharmacodynamics of Z-215 (10 mg, 20 mg, 40 mg) , compared with Rabeprazole Sodium (10 mg, 20 mg ) in Healthy Male Subjects. And to evaluate food-effect in Healthy Male Subjects administrated Z-215 20 mg.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-03
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZELOPRAZOLE | Small molecule | 10 mg | — |
| Subject | AZELOPRAZOLE | Small molecule | 20 mg | — |
| Subject | AZELOPRAZOLE | Small molecule | 40 mg | — |
| Subject | Rabeprazole | Small molecule | 10 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |
Indications
No indication recorded.